1 reports of this reaction
2.0% of all CHILDRENS PAIN RELIEF reports
#17 most reported adverse reaction
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is the #17 most commonly reported adverse reaction for CHILDRENS PAIN RELIEF, manufactured by Allegiant Health. There are 1 FDA adverse event reports linking CHILDRENS PAIN RELIEF to INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. This represents approximately 2.0% of all 50 adverse event reports for this drug.
Patients taking CHILDRENS PAIN RELIEF who experience inappropriate schedule of product administration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is a less commonly reported adverse event for CHILDRENS PAIN RELIEF, but still significant enough to appear in the safety profile.
In addition to inappropriate schedule of product administration, the following adverse reactions have been reported for CHILDRENS PAIN RELIEF:
The following drugs have also been linked to inappropriate schedule of product administration in FDA adverse event reports:
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION has been reported as an adverse event in 1 FDA reports for CHILDRENS PAIN RELIEF. This does not prove causation, but indicates an association observed in post-market surveillance data.
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION accounts for approximately 2.0% of all adverse event reports for CHILDRENS PAIN RELIEF, making it a notable side effect.
If you experience inappropriate schedule of product administration while taking CHILDRENS PAIN RELIEF, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.